Iovance Biotherapeutics (IOVA) Misses Q2 EPS by 3c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q2 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Worried the AI trade has gone too far? Evercore likes these 4 stocks